An artificial intelligence model to predict mortality among hemodialysis patients: A retrospective validated cohort study

Abstract Hemodialysis stands as the most prevalent renal replacement therapy globally. Accurately identifying mortality among hemodialysis patients is paramount importance, as it enables the formulation of tailored interventions and facilitates timely management. The objective of the study was to es...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhong Peng, Shuzhu Zhong, Xinyun Li, Fengyi Yu, Zixu Tang, Chunyuan Ma, Zihao Liao, Song Zhao, Yuan Xia, Haojun Fu, Wei Long, Mingxing Lei, Zhangxiu He
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-06576-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849237778234081280
author Zhong Peng
Shuzhu Zhong
Xinyun Li
Fengyi Yu
Zixu Tang
Chunyuan Ma
Zihao Liao
Song Zhao
Yuan Xia
Haojun Fu
Wei Long
Mingxing Lei
Zhangxiu He
author_facet Zhong Peng
Shuzhu Zhong
Xinyun Li
Fengyi Yu
Zixu Tang
Chunyuan Ma
Zihao Liao
Song Zhao
Yuan Xia
Haojun Fu
Wei Long
Mingxing Lei
Zhangxiu He
author_sort Zhong Peng
collection DOAJ
description Abstract Hemodialysis stands as the most prevalent renal replacement therapy globally. Accurately identifying mortality among hemodialysis patients is paramount importance, as it enables the formulation of tailored interventions and facilitates timely management. The objective of the study was to establish and validate an artificial intelligence (AI) model to predict mortality among hemodialysis patients. The data of 559 patients with hemodialysis at a large tertiary hospital were retrospectively analyzed, and those of 82 patients were extracted from another tertiary hospital. The patients from the large tertiary hospital constituted the model development cohort, and the patients from another tertiary hospital constituted the external validation cohort. The patients in the model development cohort were randomly divided into a training cohort and an internal validation cohort at a ratio of 8:2. The machine learning algorithms used to develop the models for the training group included logistic regression (LR), decision tree (DT), extreme gradient boosting machine (eXGBM), neural network (NN), and support vector machine (SVM). The predictive performances of all the models were evaluated using discrimination and calibration. In addition, a comprehensive scoring system to evaluate the prediction performance of the model was also used, the scoring system had the scores ranging from 0 to 50. The optimal model had the highest total score for the internal and external validation, and was further deployed as an AI application using Streamlit. The rates of mortality at one year, four years, and seven years in the model development group were determined to be 2.68%, 15.38%, and 33.09%, respectively. The model, which predicted mortality at these time points, achieved impressive area under the curve (AUC) values of 0.979 (95% CI: 0.959–0.998), 0.933 (95% CI: 0.916–0.958), and 0.935 (95% CI: 0.895–0.976), respectively, using the eXGBM model. The corresponding accuracies were 0.931, 0.889, and 0.931, with precision values of 0.891, 0.857, and 0.891, and brier scores of 0.051, 0.096, and 0.051, respectively. Notably, the eXGBM model outperformed other models with a score of 46 in the comprehensive scoring system, followed by the NN model with a score of 35. External validation further confirmed the robust predictive performance of the eXGBM model, with an AUC value of 0.892 (95% CI: 0.840–0.945). The eXGBM model emerged as the most reliable predictor of mortality among hemodialysis patients in this study. This model has been made available online at https://mortality-among-hemodialysis-bpypyb4dxvq4hja29kwsev.streamlit.app/ . Users can simply access the link, input relevant features, and receive predictions on mortality risk. Furthermore, the AI model provides insights into how the predictions were generated and offers personalized recommendations for intervention strategies. This study has successfully developed and validated an AI application for assessing mortality risk in hemodialysis patients. This tool empowers healthcare professionals to promptly identify individuals at high risk of mortality, thereby aiding in clinical decision-making and intervention planning. For patients at high risk of early death, caution is advised when considering kidney transplant surgery. Conversely, for those with a high probability of extended survival, kidney transplant surgery may present a favorable treatment option.
format Article
id doaj-art-6fa28664f04f46dc882287ec64bd4565
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-6fa28664f04f46dc882287ec64bd45652025-08-20T04:01:52ZengNature PortfolioScientific Reports2045-23222025-07-0115111710.1038/s41598-025-06576-8An artificial intelligence model to predict mortality among hemodialysis patients: A retrospective validated cohort studyZhong Peng0Shuzhu Zhong1Xinyun Li2Fengyi Yu3Zixu Tang4Chunyuan Ma5Zihao Liao6Song Zhao7Yuan Xia8Haojun Fu9Wei Long10Mingxing Lei11Zhangxiu He12Department of Nephrology, Yiyang Central HospitalDepartment of Nephrology, Yiyang Central HospitalDepartment of Nephrology, Yiyang Central HospitalDepartment of Nephrology, Yiyang Central HospitalDepartment of Nephrology, Yiyang Central HospitalDepartment of Nephrology, Suzhou Ninth People’s HospitalDepartment of Nephrology, Yiyang Central HospitalDepartment of Nephrology, Yiyang Central HospitalDepartment of Nephrology, Yiyang Central HospitalDepartment of Nephrology, Yiyang Central HospitalDepartment of Nephrology, Yiyang Central HospitalDepartment of Orthopedic Surgery, Hainan Hospital of Chinese PLA General HospitalDepartment of Nephrology, Yiyang Central HospitalAbstract Hemodialysis stands as the most prevalent renal replacement therapy globally. Accurately identifying mortality among hemodialysis patients is paramount importance, as it enables the formulation of tailored interventions and facilitates timely management. The objective of the study was to establish and validate an artificial intelligence (AI) model to predict mortality among hemodialysis patients. The data of 559 patients with hemodialysis at a large tertiary hospital were retrospectively analyzed, and those of 82 patients were extracted from another tertiary hospital. The patients from the large tertiary hospital constituted the model development cohort, and the patients from another tertiary hospital constituted the external validation cohort. The patients in the model development cohort were randomly divided into a training cohort and an internal validation cohort at a ratio of 8:2. The machine learning algorithms used to develop the models for the training group included logistic regression (LR), decision tree (DT), extreme gradient boosting machine (eXGBM), neural network (NN), and support vector machine (SVM). The predictive performances of all the models were evaluated using discrimination and calibration. In addition, a comprehensive scoring system to evaluate the prediction performance of the model was also used, the scoring system had the scores ranging from 0 to 50. The optimal model had the highest total score for the internal and external validation, and was further deployed as an AI application using Streamlit. The rates of mortality at one year, four years, and seven years in the model development group were determined to be 2.68%, 15.38%, and 33.09%, respectively. The model, which predicted mortality at these time points, achieved impressive area under the curve (AUC) values of 0.979 (95% CI: 0.959–0.998), 0.933 (95% CI: 0.916–0.958), and 0.935 (95% CI: 0.895–0.976), respectively, using the eXGBM model. The corresponding accuracies were 0.931, 0.889, and 0.931, with precision values of 0.891, 0.857, and 0.891, and brier scores of 0.051, 0.096, and 0.051, respectively. Notably, the eXGBM model outperformed other models with a score of 46 in the comprehensive scoring system, followed by the NN model with a score of 35. External validation further confirmed the robust predictive performance of the eXGBM model, with an AUC value of 0.892 (95% CI: 0.840–0.945). The eXGBM model emerged as the most reliable predictor of mortality among hemodialysis patients in this study. This model has been made available online at https://mortality-among-hemodialysis-bpypyb4dxvq4hja29kwsev.streamlit.app/ . Users can simply access the link, input relevant features, and receive predictions on mortality risk. Furthermore, the AI model provides insights into how the predictions were generated and offers personalized recommendations for intervention strategies. This study has successfully developed and validated an AI application for assessing mortality risk in hemodialysis patients. This tool empowers healthcare professionals to promptly identify individuals at high risk of mortality, thereby aiding in clinical decision-making and intervention planning. For patients at high risk of early death, caution is advised when considering kidney transplant surgery. Conversely, for those with a high probability of extended survival, kidney transplant surgery may present a favorable treatment option.https://doi.org/10.1038/s41598-025-06576-8HemodialysisMortalityMachine learningPrediction modelsExternal validation
spellingShingle Zhong Peng
Shuzhu Zhong
Xinyun Li
Fengyi Yu
Zixu Tang
Chunyuan Ma
Zihao Liao
Song Zhao
Yuan Xia
Haojun Fu
Wei Long
Mingxing Lei
Zhangxiu He
An artificial intelligence model to predict mortality among hemodialysis patients: A retrospective validated cohort study
Scientific Reports
Hemodialysis
Mortality
Machine learning
Prediction models
External validation
title An artificial intelligence model to predict mortality among hemodialysis patients: A retrospective validated cohort study
title_full An artificial intelligence model to predict mortality among hemodialysis patients: A retrospective validated cohort study
title_fullStr An artificial intelligence model to predict mortality among hemodialysis patients: A retrospective validated cohort study
title_full_unstemmed An artificial intelligence model to predict mortality among hemodialysis patients: A retrospective validated cohort study
title_short An artificial intelligence model to predict mortality among hemodialysis patients: A retrospective validated cohort study
title_sort artificial intelligence model to predict mortality among hemodialysis patients a retrospective validated cohort study
topic Hemodialysis
Mortality
Machine learning
Prediction models
External validation
url https://doi.org/10.1038/s41598-025-06576-8
work_keys_str_mv AT zhongpeng anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT shuzhuzhong anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT xinyunli anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT fengyiyu anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT zixutang anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT chunyuanma anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT zihaoliao anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT songzhao anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT yuanxia anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT haojunfu anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT weilong anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT mingxinglei anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT zhangxiuhe anartificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT zhongpeng artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT shuzhuzhong artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT xinyunli artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT fengyiyu artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT zixutang artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT chunyuanma artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT zihaoliao artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT songzhao artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT yuanxia artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT haojunfu artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT weilong artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT mingxinglei artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy
AT zhangxiuhe artificialintelligencemodeltopredictmortalityamonghemodialysispatientsaretrospectivevalidatedcohortstudy